Nov 17, 2017 7:00am EST Can-Fite’s Former Subsidiary OphthaliX Successfully Completes Merger with Wize Pharma
Oct 30, 2017 9:50am EDT Can-Fite Announces Enrollment of First Patient in its ACRobat Phase III Trial of Piclidenoson in Rheumatoid Arthritis
Oct 17, 2017 7:00am EDT Can-Fite Issued Patent in Korea for Piclidenoson in the Treatment of Psoriasis
Oct 16, 2017 7:00am EDT Can-Fite to Present at 2017 AASLD Liver Meeting Conference in Washington, D.C.
Oct 09, 2017 7:00am EDT Can-Fite CEO Dr. Pnina Fishman to Present as Expert Speaker at NASH Summit Europe in Frankfurt, Germany on October 12, 2017
Sep 18, 2017 7:00am EDT Can-Fite Files Patent Application to Treat Cytokine Release Syndrome, a Potentially Life-Threatening Complication of CAR-T Cell Therapy
Sep 01, 2017 7:00am EDT Can-Fite Reports Second Quarter 2017 Financial Results & Provides Clinical Update
Aug 23, 2017 7:00am EDT Can-Fite Receives Milestone Payment From CKD Pharmaceuticals its Distribution Partner in Korea
Aug 09, 2017 7:00am EDT Can-Fite Completes Patient Enrolment for its Phase II Study of Namodenoson in the Treatment of Liver Cancer
